Literature DB >> 4022580

Neodymium: YAG laser trabeculopuncture in open-angle glaucoma.

D L Epstein, S Melamed, C A Puliafto, R F Steinert.   

Abstract

Ten eyes of eight patients with open-angle glaucoma (OAG) had neodymium (Nd):YAG trabeculopuncture performed in an investigational protocol as an alternative to surgical intervention. In each, at four to six sites in the mid-trabecular meshwork, three to six superimposed applications were made (2 to 6 mJ). In four of six patients with adult OAG, a small decrease in intraocular pressure (IOP) was noted (from a mean of 25.5 to 20.0 mmHg after 3-4 weeks in the treated eyes, compared to no change at 21 mmHg in the fellow eyes). There appeared to be further attenuation of this IOP effect over the subsequent 2 to 11 months, and all patients demonstrated gonioscopic closure of all the puncture sites with time. One patient demonstrated an acute IOP elevation to 58 mmHg after the procedure, necessitating emergency filtration surgery. In contrast, in four eyes of two patients with juvenile open angle glaucoma, a dramatic lowering of IOP and improvement in tonographic outflow facility was demonstrated, although the effects were only temporary in one patient. YAG laser treatment to the trabecular meshwork may have its greatest potential usefulness when abnormalities in the uveal meshwork are involved, such as in certain cases of juvenile or congenital glaucoma, and may help identify the need for a surgical goniotomy. With more usual forms of OAG, however, widespread use of this technique should be avoided until greater efficacy can be achieved.

Entities:  

Mesh:

Year:  1985        PMID: 4022580     DOI: 10.1016/s0161-6420(85)33932-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Ab interno infrared laser trabecular ablation: preliminary short-term results in patients with open-angle glaucoma.

Authors:  T S Dietlein; P C Jacobi; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

2.  Effects of Er:YAG laser trabecular ablation on outflow facility in cadaver porcine eyes.

Authors:  P C Jacobi; T S Dietlein; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

Review 3.  Techniques and outcomes of minimally invasive trabecular ablation and bypass surgery.

Authors:  Kevin Kaplowitz; Joel S Schuman; Nils A Loewen
Journal:  Br J Ophthalmol       Date:  2013-12-12       Impact factor: 4.638

4.  Technique of goniocurettage: a potential treatment for advanced chronic open angle glaucoma.

Authors:  P C Jacobi; T S Dietlein; G K Krieglstein
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

5.  Internal ablative sinostomy using a fiber delivered Q-switched CTE: YAG laser (2.69 microns).

Authors:  O Kermani; H Lubatschowski; W Ertmer; G K Krieglstein
Journal:  Int Ophthalmol       Date:  1993-08       Impact factor: 2.031

6.  Trabeculopuncture as a predictive test of distal outflow resistance in canal-based surgery.

Authors:  R Verma-Fuehring; M Dakroub; H Han; J Hillenkamp; N A Loewen
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

7.  Pulsed neodymium-YAG laser trabeculotomy: energy requirements and replicability.

Authors:  G N Dutton; D Allan; S A Cameron
Journal:  Br J Ophthalmol       Date:  1989-03       Impact factor: 4.638

8.  Parameters for neodymium-YAG laser trabeculotomy: an in-vitro study.

Authors:  G N Dutton; S A Cameron; D Allan; R Thomas
Journal:  Br J Ophthalmol       Date:  1987-10       Impact factor: 4.638

9.  Nd:YAG laser trabeculopuncture (YLT) for glaucoma with traumatic angle recession.

Authors:  T Fukuchi; K Iwata; S Sawaguchi; T Nakayama; J Watanabe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-10       Impact factor: 3.117

10.  Modified Deep Sclerectomy for the Surgical Treatment of Glaucoma.

Authors:  Farideh Sharifipour; Shahin Yazdani; Mona Asadi; Azadeh Saki; Kouros Nouri-Mahdavi
Journal:  J Ophthalmic Vis Res       Date:  2019 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.